Lipoprotein Lipase Antikörper (AA 300-327)
Kurzübersicht für Lipoprotein Lipase Antikörper (AA 300-327) (ABIN3031635)
Target
Alle Lipoprotein Lipase (LPL) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 300-327
-
Kreuzreaktivität (Details)
- Expected species reactivity: Mouse, Rat, Bovine, Pig
-
Aufreinigung
- Antigen affinity purified
-
Immunogen
- A portion of amino acids 300-327 from the human protein was used as the immunogen for this LPL antibody.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Titration of the LPL antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 1:1000,IHC (Paraffin): 1:10-1:50,Flow Cytometry: 1:10-1:50
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Aliquot the LPL antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
-
-
- Lipoprotein Lipase (LPL)
-
Andere Bezeichnung
- LPL
-
Hintergrund
- LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism. [provided by RefSeq].
-
UniProt
- P06858
-
Pathways
- Lipid Metabolism
Target
-